Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms

EZH2 is a component of the polycomb repressive complex 2 (PRC2), which is a highly conserved histone methyltransferase that methylates lysine 27 of histone 3. EZH2 mutations are associated with oncogenesis and progression of cancers. However, the relationship between the clinical outcome of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qi, Han, Qi, Zi, Jie, Ma, Jinlong, Song, Huihui, Tian, Yulu, McGrath, Mary, Song, Chunhua, Ge, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997607/
https://www.ncbi.nlm.nih.gov/pubmed/32042866
http://dx.doi.org/10.1016/j.gendis.2019.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997607/
https://www.ncbi.nlm.nih.gov/pubmed/32042866
http://dx.doi.org/10.1016/j.gendis.2019.05.001

Ejemplares similares